Market Overview:
The global avanafil market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of erectile dysfunction, increasing awareness about avanafil and its benefits, and growing demand for novel treatment options for erectile dysfunction. The global avanafil market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 50 mg avanafil, 100 mg avanafil, and 200 mg avanafil. On the basis of application, the market is segmented into young man (18-40 years), middle-aged person (41-60 years), and others (61 years or older). The North America region dominates the global avanafil market followed by Europe.
Product Definition:
Avanafil is a drug that is used to treat erectile dysfunction. It is in a class of drugs called phosphodiesterase type 5 inhibitors. It works by increasing blood flow to the penis, which helps to maintain an erection.
50 mg Avanafil:
Avanafil is used to treat Erectile Dysfunction (ED) and pulmonary arterial hypertension in patients. ED is the inability to achieve an erection sufficient for sexual intercourse. Avanafil 50 mg tablet is a PDE-5 inhibitor which works by increasing blood flow into the penis during sexual stimulation. It helps in achieving and maintaining an erection, thus enabling successful intercourse.
100 mg Avanafil:
AVD 100 mg is used to treat Erectile Dysfunction (ED) and pulmonary arterial hypertension in patients. ED is the inability to achieve an erection sufficient for sexual intercourse. Avanafil acts as a blood pressure regulator by relaxing the smooth muscle cells in the arteries and veins which allows more blood flow through them, thus increasing oxygen levels in penile tissues.
Application Insights:
The others application segment dominated the global market in 2017, accounting for over 50.0% share of the total revenue. Rising awareness about erection and maintaining an erection for a longer period is expected to drive this segment over the forecast period. Increasing number of prescriptions being written by healthcare professionals for avanafil tablets to treat erectile dysfunction is further anticipated to fuel market growth during the forecast period.
The young man application segment accounted for a significant share in 2017 owing to increasing awareness about safe sex among youth population across various regions including North America and Europe.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players and high demand for erectile dysfunction treatment are some factors driving the regional market. In addition, increasing cases of diabetes is also expected to boost product demand in North America during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rising healthcare expenditure, growing population, and rising awareness about avanafil citrate tablets among men suffering from ED.
Growth Factors:
- Increasing prevalence of erectile dysfunction (ED) due to aging population and unhealthy lifestyle.
- Growing awareness about the availability and benefits of avanafil therapy among men with ED.
- Launch of new avanafil products with improved efficacy and safety profile by key players in the market.
- increasing investment by pharmaceutical companies in research and development for new avanafil products .
Scope Of The Report
Report Attributes
Report Details
Report Title
Avanafil Market Research Report
By Type
50 mg Avanafil, 100 mg Avanafil, 200 mg Avanafil
By Application
The Young Man, Middle-Aged Person, Others
By Companies
VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International, JW Pharmaceutical, VIVUS Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Avanafil Market Report Segments:
The global Avanafil market is segmented on the basis of:
Types
50 mg Avanafil, 100 mg Avanafil, 200 mg Avanafil
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
The Young Man, Middle-Aged Person, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- VIVUS Inc
- Sanofi
- Menarini Group
- Auxilium Pharmaceuticals
- Endo International
- JW Pharmaceutical
- VIVUS Inc
Highlights of The Avanafil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50 mg Avanafil
- 100 mg Avanafil
- 200 mg Avanafil
- By Application:
- The Young Man
- Middle-Aged Person
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Avanafil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Avanafil is a medication used to treat erectile dysfunction (ED). It works by increasing blood flow to the penis.
Some of the key players operating in the avanafil market are VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International, JW Pharmaceutical, VIVUS Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Avanafil Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Avanafil Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Avanafil Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Avanafil Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Avanafil Market Size & Forecast, 2020-2028
4.5.1 Avanafil Market Size and Y-o-Y Growth
4.5.2 Avanafil Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50 mg Avanafil
5.2.2 100 mg Avanafil
5.2.3 200 mg Avanafil
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 The Young Man
6.2.2 Middle-Aged Person
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Avanafil Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Avanafil Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50 mg Avanafil
9.6.2 100 mg Avanafil
9.6.3 200 mg Avanafil
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 The Young Man
9.10.2 Middle-Aged Person
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50 mg Avanafil
10.6.2 100 mg Avanafil
10.6.3 200 mg Avanafil
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 The Young Man
10.10.2 Middle-Aged Person
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50 mg Avanafil
11.6.2 100 mg Avanafil
11.6.3 200 mg Avanafil
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 The Young Man
11.10.2 Middle-Aged Person
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50 mg Avanafil
12.6.2 100 mg Avanafil
12.6.3 200 mg Avanafil
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 The Young Man
12.10.2 Middle-Aged Person
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50 mg Avanafil
13.6.2 100 mg Avanafil
13.6.3 200 mg Avanafil
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 The Young Man
13.10.2 Middle-Aged Person
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Avanafil Market: Competitive Dashboard
14.2 Global Avanafil Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 VIVUS Inc
14.3.2 Sanofi
14.3.3 Menarini Group
14.3.4 Auxilium Pharmaceuticals
14.3.5 Endo International
14.3.6 JW Pharmaceutical
14.3.7 VIVUS Inc
